Skip to Main Content

Paper Details

Comparison of Dimethyl Fumarate vs Fingolimod and Rituximab vs Natalizumab for Treatment of Multiple Sclerosis.
JAMA Netw Open
17
2021
Dimethyl Fumarate, Fingolimod, Multiple Sclerosis, Natalizumab, Participants, Rituximab, dimethyl fumarate, fingolimod, multiple sclerosis, natalizumab, rituximab, women
Author NameAffiliation
Howard L WeinerBrigham and Women's Hospital
Tianxi CaiHarvard T.H. Chan School of Public Health
Tianxi CaiHarvard Medical School
Tianxi CaiHarvard T.H. Chan School of Public Health
Tianxi CaiHarvard Medical School
Zongqi XiaUniversity of Pittsburgh
Zongqi XiaUniversity of Pittsburgh
Zongqi XiaUniversity of Pittsburgh
Zongqi XiaUniversity of Pittsburgh
  • 1 - 9

Datasets

Release 1.2